Crosbie EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, Powell ME, Singh N. Endometrial cancer. Lancet. 2022;399(10333):1412–28. https://doi.org/10.1016/S0140-6736(22)00323-3.
Makker V, MacKay H, Ray-Coquard I, Levine DA, Westin SN, Aoki D, et al. Endometrial cancer. Nat Rev Dis Primers. 2021;7(1):88. https://doi.org/10.1038/s41572-021-00324-8.
Article PubMed PubMed Central Google Scholar
Zhao S, Chen L, Zang Y, Liu W, Liu S, Teng F, Xue F, Wang Y. Endometrial cancer in Lynch syndrome. Int J Cancer. 2022;150(1):7–17. https://doi.org/10.1002/ijc.33763.
Article CAS PubMed Google Scholar
Corr BR, Erickson BK, Barber EL, Fisher CM, Slomovitz B. Advances in the management of endometrial cancer. BMJ. 2025;380: e080978. https://doi.org/10.1136/bmj-2024-080978.
Bogani G, Monk BJ, Powell MA, Westin SN, Slomovitz B, Moore KN, et al. Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer. Ann Oncol. 2024;35(5):414–28. https://doi.org/10.1016/j.annonc.2024.02.006.
Article CAS PubMed Google Scholar
van den Heerik ASVM, Horeweg N, de Boer SM, Bosse T, Creutzberg CL. Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy. Int J Gynecol Cancer. 2021;31(4):594–604. https://doi.org/10.1136/ijgc-2020-001822.
Karpel H, Slomovitz B, Coleman RL, Pothuri B. Biomarker-driven therapy in endometrial cancer. Int J Gynecol Cancer. 2023;33(3):343–50. https://doi.org/10.1136/ijgc-2022-003676.
Dexter J, Lips E, DiSilvestro P. Adjuvant therapy in node-positive endometrial cancer: a focus on chemotherapy. Curr Oncol Rep. 2022;24(12):1677–83. https://doi.org/10.1007/s11912-022-01327-8.
Article CAS PubMed Google Scholar
Rubio-Sánchez R, Ríos-Reina R, Ubeda C. Effect of chemotherapy on urinary volatile biomarkers for lung cancer by HS-SPME-GC-MS and chemometrics. Thorac Cancer. 2023;14(36):3522–9. https://doi.org/10.1111/1759-7714.15154.
Article CAS PubMed PubMed Central Google Scholar
Ledesma M, Poodts D, Amoia S, Hajos S, Fundia A, Vay C, et al. Discrimination of the chemotherapy resistance status of human leukemia and glioblastoma cell lines by MALDI-TOF-MS profiling. Sci Rep. 2023;13(1): 13426. https://doi.org/10.1038/s41598-023-32608-2.
Cui L, Lu Y, Zheng J, Guo B, Zhao X. ACTN1 promotes HNSCC tumorigenesis and cisplatin resistance via MYH9-dependent degradation of GSK-3β and integrin β1-mediated FAK phosphorylation. J Exp Clin Cancer Res. 2023;42(1):270. https://doi.org/10.1186/s13046-023-02904-w.
Ploypetch S, Jaresitthikunchai J, Phaonakrop N, Sakcamduang W, Manee-in S, Suriyaphol P, Roytrakul S, Suriyaphol G. Utilizing MALDI-TOF MS and LC-MS/MS to access serum peptidome-based biomarkers in canine oral tumors. Sci Rep. 2022;12(1): 21641. https://doi.org/10.1038/s41598-022-26132-y.
Article CAS PubMed PubMed Central Google Scholar
Van Houdt M, Han SN, Pauwels S, Billen J, Neven P. Measurable serum estradiol and estrone in women during adjuvant aromatase inhibitor therapy for breast cancer. Clin Breast Cancer. 2023;23(1):84–90. https://doi.org/10.1016/j.clbc.2022.09.007.
Article CAS PubMed Google Scholar
Ren H, Wu Z, Tan J, Tao H, Zou W, Cao Z, et al. Co-delivery nanosystem of MS-275 and V-9302 induces pyroptosis and enhances antitumor immunity against uveal melanoma. Adv Sci. 2024;11(31):2404375. https://doi.org/10.1002/advs.202404375.
Li HWR, Robertson DM, Burns C, Ledger WL. Challenges in measuring AMH in the clinical setting. Front Endocrinol (Lausanne). 2021;12:691432. https://doi.org/10.3389/fendo.2021.691432.
Ayuandari S, Dewanto A, Oktasari R, Rahmawati NR, Alma NA, Hamurajib KC, et al. Anti-Müllerian hormone and puberty development in girls and adolescents who underwent cancer treatment. Arch Gynecol Obstet. 2022;305(6):1581–6. https://doi.org/10.1007/s00404-021-06364-5.
Article CAS PubMed Google Scholar
Safi S, Krzykalla J, Hoffmann H, Benner A, Bischoff H, Eichhorn M, et al. Low tumor interleukin-1β predicts limited benefit of adjuvant platinum chemotherapy in resected lung adenocarcinoma. Pulmonology. 2024;31(1):e21–9. https://doi.org/10.1016/j.pulmoe.2024.03.003.
Jin CL, Shi XG, Wang TT, Li HW, Zhang DX, Sheng Z, et al. Value of echocardiography and cardiac magnetic resonance in assessing left ventricular function in cancer patients after anthracycline therapy. BMC Cardiovasc Disord. 2023;23(1):452. https://doi.org/10.1186/s12872-023-03495-2.
Zhang S, Jiang C, Jiang L, Chen H, Huang J, Gao X, et al. Diagnostic model for hepatitis B-related hepatocellular carcinoma using machine learning and neural networks. Tumour Virus Res. 2023;16:200271. https://doi.org/10.1016/j.tvr.2023.200271.
Article CAS PubMed PubMed Central Google Scholar
Yalcin S, Philip PA, Athanasiadis I, Bazarbashi S, Shamseddine A. Classification of early-stage colon cancer with Immunoscore: clinical evidence and case studies. Future Oncol. 2021;18(5):613–23. https://doi.org/10.2217/fon-2021-0712.
Article CAS PubMed Google Scholar
Li H, Liu T, Zhao L, Xiao Z, Su X, Deng X, et al. Noble metal nanomaterials for diagnosis and treatment of hematological malignancies. Front Biosci (Landmark Ed). 2022;27(2):47. https://doi.org/10.31083/j.fbl2702040.
Huang X, Sheng B, Tian H, Chen Q, Yang Y, Bui B, et al. Real-time SERS monitoring of anticancer drug release with SERS/MR imaging for pH-sensitive chemo-phototherapy. Acta Pharm Sin B. 2023;13(3):1303–17. https://doi.org/10.1016/j.apsb.2022.08.024.
Article CAS PubMed Google Scholar
Yang B, Dai X, Chen S, Li C, Yan B. Application of surface-enhanced Raman spectroscopy in head and neck cancer diagnosis. Anal Chem. 2025;97(7):3781–98. https://doi.org/10.1021/acs.analchem.4c02796.
Article CAS PubMed Google Scholar
Chen B, Qiu X, Li Y. Exosomes in ovarian cancer: impact on drug resistance and advances in SERS detection techniques. J Pharm Anal. 2025;15(7):101170. https://doi.org/10.1016/j.jpha.2024.101170.
Article CAS PubMed Google Scholar
Xing X, Zhong W, Tang P, Tao Q, Lu X, Zhong L. Tracking intracellular nuclear-targeted chemotherapy of chidamide-loaded Prussian blue nanocarriers by SERS mapping. Colloids Surf B Biointerfaces. 2023;229:113469. https://doi.org/10.1016/j.colsurfb.2023.113469.
Article CAS PubMed Google Scholar
Chen S, Wang C, Zhu R, Zhu S, Zhang G. Predicting prognosis in acute myeloid leukemia patients by surface-enhanced Raman spectroscopy. Nanomedicine (Lond). 2021;16(21):1873–85. https://doi.org/10.2217/nnm-2021-0199.
Article CAS PubMed Google Scholar
Zhang X, Ge Y, Liu M, Pei Y, He P, Song W, et al. DNA-Au janus nanoparticles for in situ SERS detection and targeted chemo-photodynamic synergistic therapy. Anal Chem. 2022;94(22):7823–32. https://doi.org/10.1021/acs.analchem.1c05649.
Shin H, Choi BH, Shim O, Kim J, Park Y, Cho SK, et al. Single-test diagnosis of multiple cancer types using Exosome-SERS-AI for early-stage cancers. Nat Commun. 2023;14(1):1948. https://doi.org/10.1038/s41467-023-37403-1.
Chen Z, Chen K, Yu W, Wang X, He X, Zhang Q, et al. SERS-AI based detection and bioanalysis of malodorous components in kitchen waste. Anal Chem. 2024;96(49):19615–22. https://doi.org/10.1021/acs.analchem.4c04699.
Comments (0)